Download PDF
Thromb Haemost 2000; 84(03): 362-363
DOI: 10.1055/s-0037-1614028
Commentary
Schattauer GmbH

Control of Oral Anticoagulant Therapy with Whole Blood Prothrombin Time Devices: the Future Has Begun

Armando Tripodi
1   From the Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre, Department of Internal Medicine, University and IRCCS Maggiore Hospital, Milano, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
14 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Lucas FV, Duncan A, Jay R, Coleman R, Craft P, Chan B, Winfrey L, Mungall DR, Hirsh J. A novel whole blood capillary technique for measuring the prothrombin time. Am J Clin Pathol 1987; 88: 442-6.
    CrossrefPubMedGoogle Scholar
  • 2 Ansell J, Holden A, Knapic RN. Patient self management of oral anticoagulation guided by a capillary (fingerstick) whole blood prothrombin times. Arch Int Med 1989; 149: 2509-11.
    CrossrefPubMedGoogle Scholar
  • 3 White RH, Mc SACurdy, von Marensdorff H, Woodruff Jr DE, Leftgoff L. Home prothrombin time monitoring after initiation of warfarin therapy. Ann Int Med 1989; 111: 730-7.
    CrossrefPubMedGoogle Scholar
  • 4 Poller L, Schiach CR, MacCallum PK, Johansen AM, Munster AM, Magalhaes A, Jespersen J. The European Concerted Action on Anticoagulation (ECAA) Multicentre randomised study of computerised anticoagulant dosage. The Lancet 1998; 352: 1505-9.
    CrossrefPubMedGoogle Scholar
  • 5 Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy. WHO Expert Committee on Biological Standardization. Technical Report Series 889; forty-eight report. Geneva, Switzerland: WHO;
    Google Scholar
  • 6 Tripodi A, Arbini AA, Chantarangkul V, Bettega D, Mannucci PM. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio. Thromb Haemost 1993; 70: 921-4.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Tripodi A, Chantarangkul V, Clerici M, Negri B, Mannucci PM. Determination of the International Sensitivity Index of a new near patient testing device to monitor oral anticoagulant therapy Overview on the assessment of conformity to the calibration model. Thromb Haemost 1997; 78: 855-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Kitchen S, Preston FE. Monitoring oral anticoagulant treatment with the TAS near patient test system: comparison with conventional thromboplastins. J Clin Pathol 1997; 50: 951-956.
    CrossrefPubMedGoogle Scholar
  • 9 Poller L, van den Besselaar AMHP, Jespersen J, van der Meer F, Preston FE, Tripodi A. Normalisation and standardisation of home prothrombin time (PT) monitors. Thromb Haemost. (Suppl. August 1999) 548.
    PubMedGoogle Scholar
  • 10 Van den Besselaar AMHP. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin. Thromb Haemost 2000; 84: 410-2.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Int Med 1993; 153: 1441-7.
    CrossrefPubMedGoogle Scholar
  • 12 Douketis JD, Lane A, Milne A, Ginsberg JS. Accuracy of a portable international normalization ratio monitor in outpatients receiving long term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement. Thromb Res 1998; 92: 11-7.
    CrossrefPubMedGoogle Scholar